TAAR1 as a Potential Alternate Molecular Target to GLP-1 for Novel Anti-diabetic, Anti-obesity Medications.
Saved in:
| Title: | TAAR1 as a Potential Alternate Molecular Target to GLP-1 for Novel Anti-diabetic, Anti-obesity Medications. |
|---|---|
| Authors: | Lenham RK; Department of Human Biosciences, Memorial University of Newfoundland, St. John's, Canada. rlenham@mun.ca., Elgammal F; Department of Human Biosciences, Memorial University of Newfoundland, St. John's, Canada., Harding SV; Department of Human Biosciences, Memorial University of Newfoundland, St. John's, Canada., Berry MD; Department of Human Biosciences, Memorial University of Newfoundland, St. John's, Canada. |
| Source: | Handbook of experimental pharmacology [Handb Exp Pharmacol] 2026 Jul 11. Date of Electronic Publication: 2026 Jul 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902231 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0171-2004 (Print) Linking ISSN: 01712004 NLM ISO Abbreviation: Handb Exp Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 0171-2004 |
|---|---|
| DOI: | 10.1007/164_2026_821 |
